Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart BioLineRx Ltd. Nasdaq

Equities

BLRX

US09071M2052

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/06/2024 BST 		5-day change 1st Jan Change
0.68 USD +3.88% Intraday chart for BioLineRx Ltd. -2.37% -56.69%
05-30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
05-28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
Chart BioLineRx Ltd.
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. BLRX Stock
  5. Charts BioLineRx Ltd.
  6. Static Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW